India

Portfolio

Differentiated Products

  • Fondared (Fondparinux sodium injection) is used in the management of acute coronary syndrome (ACS), deep vein thrombosis (DVT) and pulmonary embolism (PE). We are the first company, after innovator to crack the manufacturing of this complex molecule. Fondared is the only generic approved by the USFDA, and it has been present in the US market for over three years.

  • Dacotin (Oxaliplatin injection 50/100 mg) is used in the management of metastatic colorectal cancer. The product is in-licensed from the innovator - Debiopharm, a Swiss-based global biopharmaceutical group of companies. Dacotin is the market leader in the Oxaliplatin segment.

  • Reclide XR (Gliclazide 60 mg) is used in the management of Type-2 Diabetes. It is an extended release, score tablet that allows for ease of titration for managing dynamic glycemic levels effectively.

  • Metformin (Metformin Hydrochloride Sustained Release Tablet 500 mg and 1000 mg) is the first-line drug of choice for the treatment of Type-2 Diabetes, where swallowing of the tablet plays a vital role in patient compliance. The Metsmall tablet is designed to be smaller than other brands in the market. Its shape also makes it easier to swallow, thereby significantly increasing patient adherence, especially in the case of elderly patients. Metsmall is a unique innovation that delivers the same efficacy or bioequivalence as the conventional, much larger Metformin.

  • Optidoz is a single pill combination of three anti-hypertensive drugs (Amlodipine 2.5mg, Telmisartan 20mg and Hydrochlorothiazide 6.25mg) with optimal (half of standard) dose of individual drugs. It controls hypertension faster and more effectively with much lesser incidence of adverse events as compared to standard dose double drug combination. Optidoz simplifies the traditional, complicated step-care treatment approach for hypertension management.

  • Pamorelin LA (Triptorelin Pamoate) is used for the treatment of locally advanced or metastatic, hormone-dependent prostate cancer. The product provides a substitute of surgical castration, which is a traumatic experience for the patient. It also offers the advantage of once in three months injection. We are the only company in India marketing Triptorelin Pamoate. The product is in-licensed from the innovator - Debiopharm, a Swiss-based global biopharmaceutical group of companies.

  • Durolane (Hyaluronic Acid) is the original, single intra articular hyaluronic acid injection treatment to relieve the pain of knee or hip osteoarthritis. Durolane was launched in an exclusive partnership with Bioventus. It is based on the patented NASHA™ (stabilized, non-animal origin hyaluronic acid) technology.